| Financial Year |
March 31 2023 |
| Monetary Funds |
239,049,438.67 |
| Held-for-trading Financial Assets |
7,887,000.00 |
| Notes Receivable |
62,114,585.94 |
| Accounts Receivable |
561,728,106.92 |
| Advances to Suppliers |
6,683,903.75 |
| Other Receivables |
7,024,184.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
394,987,778.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
369,856.35 |
| Other Current Assets |
16,482,372.12 |
| Total Current Assets |
1,736,548,387.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,690,854.04 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
681,541,059.39 |
| Under-construction Projects |
114,696,026.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,887,108.79 |
| R&D expenses |
-- |
| Goodwill |
7,311,862.43 |
| Long-Term Deferred and Prepaid Expenses |
21,228,292.13 |
| Deferred Income Tax Assets |
8,947,922.44 |
| Other Non-Current Assets |
16,783,588.83 |
| Sub-Total of Non-Current Assets |
1,136,175,812.90 |
| Total Assets |
2,872,724,200.79 |
| Short-Term Loans |
128,029,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,931,832.68 |
| Accounts Payable |
483,066,367.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,274,907.98 |
| Taxes Payable |
5,760,566.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,532,279.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,569,970.24 |
| Other Current Liabilities |
29,565,304.20 |
| Sub-Total of Current Liabilities |
831,504,412.70 |
| Long-term Loans |
260,250,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,361,885.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
380,289,503.80 |
| Total Liabilities |
1,211,793,916.50 |
| Paid-In Capital(Or Share Stock) |
200,033,833.00 |
| Capital Surplus |
719,674,240.09 |
| Surplus Reserve |
61,830,537.05 |
| LESS:Treasury Stock |
25,569,590.01 |
| Undistributed Profits |
653,771,827.70 |
| Minority Stockholder's Interest |
50,748,698.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,610,181,586.09 |
| Owner's Equity（Stockholder's Equity） |
1,660,930,284.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,872,724,200.79 |
